Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Genesis Signs Pact with Chinese Academy of Sciences

publication date: Nov 23, 2007

Genesis Pharmaceuticals Enterprises, Inc. continued its steady flow of announcements by reporting a new cooperative agreement with The Institute of Microbiology, Chinese Academy of Sciences (IMCAS). IMCAS, which performs basic and applied research in microbiology, will work with Genesis to improve the commercialization of pharmaceutical discoveries. Genesis will be responsible for funding the daily operations of the collaboration, which will take place at IMCAS. When drugs have completed the first stage of experiments, Genesis will conduct further testing in its own facility to determine the feasibility of commercial-scale production. More details...

Stock Symbol: (OTCBB: GTEC)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital